The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...
Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--DvSum, a leader in data intelligence management, is pleased to announce its partnership with Booz Allen Hamilton and the U.S. Food and Drug Administration (FDA) to ...
DUBLIN--(BUSINESS WIRE)--The "Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance" training has been added to ResearchAndMarkets.com's offering.
FDA recently published a statement reminding medical device study sponsors and medical device manufacturers to evaluate third party’s contracted to conduct performance testing, urging independent ...
Laboratories today face mounting pressure to maintain data integrity while navigating complex compliance requirements and evolving technologies. Despite advancements, many labs still rely on ...
Kenneth J. Oh is a global marketing manager for Bio-Rad. In this current age of rapid scientific advancement, the integrity of published data has never been more critical, or more vulnerable. As ...
In research, digital images, including gel electrophoresis and Western blot images, are not only illustrations but central evidence of data, which must be verified and reproducible. Peer-reviewed ...
The EMA has started a review of Amgen Inc.’s Tavneos (avacopan) after questions were raised about the integrity of the data in the Advocate study that the agency assessed when granting approval of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results